C07C 311/33
Of a saturated carbon skeleton containing rings
Official title: of a saturated carbon skeleton containing rings
C07C311/33 (Of a saturated carbon skeleton containing rings) appears on 10 US grants and 7 published applications in this corpus.
Search patents in C07C- Granted patents
- 10
- Published applications
- 7
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 3 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 2 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Phenylalanine-based LAT1 inhibitors and uses thereof30 Sep 2025US 12,427,124 B1Maxymune Therapeutics, Inc.
- PTEN binding compounds, formulations, and uses thereof3 Aug 2021US 11,078,164 B1University of South Florida
- PTEN binding compounds, formulations, and uses thereof2 Jun 2020US 10,669,241 B2University of South Florida
- Camphor-derived compounds, method for manufacturing the same, and application thereof17 Dec 2013US 8,609,839 B2National Tsing Hua University
- Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes21 May 2013US 8,445,706 B2Board of Trustees of Northern Illinois University
- Phenylalanine-based lat1 inhibitors and uses thereof6 Nov 2025US 2025/0339388 A1Maxymune Therapeutics, Inc.
- Phenylalanine-based lat1 inhibitors and uses thereof16 Oct 2025US 2025/0319046 A1Maxymune Therapeutics, Inc.
- Pten binding compounds, formulations, and uses thereof30 May 2019US 2019/0161450 A1University of South Florida
- Processes for the preparation of a bace inhibitor17 Aug 2017US 2017/0233382 A1Merck Sharp & Dohme Corp.
- Camphor-derived compounds, method for manufacturing the same, and application thereof29 Mar 2012US 2012/0077976 A1National Tsing Hua University
Most cited
By later US patents
- Diol sulfonamide and sulfinyl renin inhibitors40US 5,098,924 AE. R. Squibb & Sons, Inc. · 1992
- 4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders14US 6,545,022 B1Pfizer Inc. · 2003
- 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders12US 6,518,289 B1Pfizer Inc. · 2003
- Amines as pharmaceutical agents2US 6,521,650 B1Pfizer Inc. · 2003
- Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes2US 8,445,706 B2Board of Trustees of Northern Illinois University · 2013